SCHEMBL8385259

SCHEMBL8385259

CCC(C(=O)O)C(=O)c1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.56
NR4A2 P43354 1/20 0.56
NR4A3 Q92570 1/20 0.56
CDC25B P30305 2/20 0.50
PTPN1 P18031 1/20 0.50
PLK1 P53350 1/20 0.50
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
TDP1 Q9NUW8 3/20 0.47
KDM4E B2RXH2 2/20 0.47
GMNN O75496 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
MAPK1 P28482 2/20 0.47
BLM P54132 2/20 0.47
PMP22 Q01453 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28740658 0.84 NR4A1 (0.50) NR4A1NR4A2NR4A3CDC25BPTPN1
SCHEMBL25384255 0.84 CDC25B (0.51) NR4A1NR4A2NR4A3CDC25BPTPN1
SCHEMBL30546550 0.84 CDC25B (0.51) NR4A1NR4A2NR4A3CDC25BPTPN1
SCHEMBL15658687 0.81 NR4A1 (0.53) NR4A1NR4A2NR4A3CDC25BPTPN1
SCHEMBL4114028 0.79 PTPN1 (0.54) NR4A1NR4A2NR4A3CDC25BPTPN1
SCHEMBL1878466 0.79 SLC6A2 (0.48) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL25384484 0.77 CDC25B (0.42) NR4A1NR4A2NR4A3CDC25BPLK1
SCHEMBL4326257 0.77 CES2 (0.50) PTPN1MEN1KMT2ATDP1KDM4E
SCHEMBL2292145 0.77 ALDH1A1 (0.52) ALDH1A1POLBHPGDTP53TSHR
SCHEMBL27960653 0.77 CES2 (0.50) PTPN1MEN1KMT2ATDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958934-A 5-HT 2B ANTAGONIST SYNTEX (U.S.A.) INC. (US) 1999-09-28 US disclosed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 US disclosed